| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9954467 | Lung Cancer | 2018 | 27 Pages |
Abstract
These results demonstrate an important phenotypic CTCs heterogeneity based on the co-expression of Bcl-2, CK, Vim and M30 in SCLC patients. The changes of Bcl-2+/CD45â CTCs during treatment seem to be a dynamic biomarker associated with treatment efficacy and patients' clinical outcome.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ippokratis Messaritakis, Michail Nikolaou, Eleni Politaki, Fillipos Koinis, Eleni Lagoudaki, Anastasios Koutsopoulos, Nefeli Georgoulia, Vassilis Georgoulias, Athanasios Kotsakis,